Anatara Lifesciences Ltd (AU:ANR) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Anatara Lifesciences Ltd has announced a securities purchase plan, proposing to issue up to 10 million fully paid ordinary shares. This move, set to conclude by December 18, 2024, provides an opportunity for investors to acquire shares in the biotech firm. The issuance reflects Anatara’s strategy to bolster its financial standing and support its growth initiatives.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.